Europe — EMA
Iricryn
GNH USA supplies Iricryn (Bimatoprost), a prostaglandin analog for open‑angle glaucoma, ocular hypertension and eyelash hypotrichosis.
Request sourcing
What is Bimatoprost?
Bimatoprost, the active ingredient in Iricryn, is a prostaglandin analog presented as a 0.01% w/v ophthalmic solution for ocular use. It treats open‑angle glaucoma, ocular hypertension and can promote eyelash growth in patients with hypotrichosis.
GNH USA supplies Iricryn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Bimatoprost used for?
Bimatoprost is a prostaglandin analog used to lower intraocular pressure in ocular conditions.
Open‑angle glaucoma: reduces intraocular pressure to prevent optic nerve damage. Ocular hypertension: lowers eye pressure to reduce the risk of progression to glaucoma. Hypotrichosis of eyelashes: promotes longer, darker eyelashes to improve appearance.
What are the side effects of Bimatoprost?
Bimatoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.
Common Side Effects: - Eye redness - Eye itching - Eyelash darkening - Eyelash lengthening - Eye irritation - Blurred vision
Serious or Rare Side Effects: - Iridocyclitis - Severe conjunctival hyperemia - Periorbital skin darkening - Vision loss - Allergic reaction (including anaphylaxis) - Macular edema
What precautions apply to Bimatoprost?
Before using Iricryn, consider the following precautions.
Pregnancy: Category C – use only if potential benefit justifies potential risk. Breastfeeding: Caution – limited data, evaluate risk versus benefit. Contraindications: Do not use in patients with active intraocular inflammation. Monitoring: Regular intraocular pressure checks are recommended. Drug interactions: Review concomitant ocular medications for additive pressure‑lowering effects. Store at room temperature: keep in the original container, protect from light and moisture.
What does Bimatoprost interact with?
Bimatoprost can interact with other ocular or systemic agents; monitor patients accordingly.
Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory eye drops: may reduce efficacy. - Systemic carbonic anhydrase inhibitors: additive intraocular pressure lowering may cause hypotony. - Other prostaglandin analogues: increased risk of ocular hyperemia.
Moderate Interactions (Monitor Closely): - Topical beta‑blockers: combined effect on intraocular pressure, monitor closely. - Corticosteroid eye drops: may counteract pressure‑lowering effect. - Contact lens wear: may increase drug absorption; advise removal before instillation.
Frequently asked questions
What is Iricryn used for?+
How does bimatoprost work?+
What is the usual dose of Iricryn?+
Is Iricryn safe during pregnancy or breastfeeding?+
How do I order Iricryn from GNH USA?+
How does Iricryn compare with other glaucoma eye drops?+
How should I store Iricryn?+
How is Iricryn administered?+
What are the most serious risks to watch for with Iricryn?+
Who should not use Iricryn?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo